BioSpace News Archive

Deals

Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States.

November 14, 2018
·
4 min read
Drug Development

Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections

--Data presented at 6th ISIVR-AVG Conference--

November 14, 2018
·
5 min read
NICO Awards First Investigator Initiated Study Grant to Mayo Clinic

Grant supports physician-led evaluation of MIS technologies on ICH treatment

November 14, 2018
·
2 min read
Genetown

Advanced Aesthetic Technologies Announces New Financing on Netcapital Private Securities Platform

AAT to raise equity financing via Netcapital funding portal

November 14, 2018
·
3 min read
FDA

Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality™ (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache

Lilly also plans to submit a supplemental Biologics License Application (sBLA) to the FDA for Emgality for the preventive treatment of episodic cluster headache by the end of the year, reflecting its commitment to disabling headache disorders

November 14, 2018
·
10 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Compared to Chemotherapy in Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Express PD-L1 (CPS ≥10)

With Pivotal KEYNOTE-181 Trial Meeting Primary Endpoint of OS, KEYTRUDA Becomes the First Anti-PD-1 Therapy to Demonstrate a Survival Benefit for These Patients

November 14, 2018
·
27 min read
Pharm Country

WindRose Health Investors, LLC Announces Recapitalization of Traditions Behavioral Health

TBH manages all aspects of psychiatric staffing for its customers, including recruitment, on-boarding, training, scheduling, directorship, and documentation, among others.

November 14, 2018
·
3 min read
Business

CareCredit & MDsave Launch Strategic Partnership Helping Improve Access To Healthcare

Leading Healthcare Marketplace Offers Financing Options Designed to Help Customers Finance Healthcare Expenses

November 14, 2018
·
4 min read
Business

Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement

Precision BioSciences gains rights to MaxCyte’s cell engineering technology to develop next-generation, oncology-focused, cell therapies with Precision’s ARCUS® genome-editing technology

November 14, 2018
·
3 min read
Business

CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results

Key new hires include Chief Financial Officer and President, CASI China as CASI prepares for global commercialization efforts

November 14, 2018
·
10 min read